netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

Chapter Links...
 Details...
03.01.04  Expand sub section  Compound bronchodilator preparations
 note  Patients established on inhaler devices not on the formulary only to be switched to an alternative device if part of a formal clinical review
Anoro Ellipta® dry powder inhlaer (umeclidinium and vilaterol)
View adult BNF View SPC online
Formulary  
   
Duaklir Genuair® dry powder inhaler (aclidinium and formoterol)
View adult BNF View SPC online
Formulary  
   
Ultibro Breezhaler® dry powder inhlaer (glycopyronium and indacaterol)
View adult BNF View SPC online
Formulary  
   
Ipratropium with salbutamol nebules (Combivent®)
View adult BNF View SPC online
Formulary  
   
Spiolto® Respimat® inhaler device (tiotropium and olodaterol)
View adult BNF View SPC online
Formulary
Green

Combination inhaler device for use as a maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD

Refer to SE London integrated guideline for COPD in adults and the SEL formulary recommendation for detailed prescribing guidance

 
Link  SEL APC recommendation: Spiolto® Respimat® (tiotropium/olodaterol) inhalation solution for the treatment of chronic obstructive pulmonary disease (COPD) in adults
Link  South East London Integrated Guideline for the Management of COPD
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

Amber 1

Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

Amber 2

Specialist initiation followed by maintenance prescribing in primary care  

Amber 3

Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

Green

Specialist and non-specialist initiation  

Grey

Not recommended for prescribing  

netFormulary